|
FLRT3 |
fibronectin leucine rich transmembrane protein 3 |
- Signaling by ROBO receptors
- Downstream signaling of activated FGFR1
|
|
|
|
FRS2 |
fibroblast growth factor receptor substrate 2 |
- PI3K Cascade
- PIP3 activates AKT signaling
- Frs2-mediated activation
- Frs2-mediated activation
- Constitutive Signaling by Aberrant PI3K in Cancer
- PI-3K cascade:FGFR1
- FRS-mediated FGFR1 signaling
- PI-3K cascade:FGFR2
- FRS-mediated FGFR2 signaling
- FRS-mediated FGFR3 signaling
- PI-3K cascade:FGFR3
- FRS-mediated FGFR4 signaling
- PI-3K cascade:FGFR4
- Negative regulation of FGFR1 signaling
- Negative regulation of FGFR2 signaling
- Negative regulation of FGFR3 signaling
- Negative regulation of FGFR4 signaling
- Signaling by FGFR2 in disease
- Signaling by FGFR4 in disease
- Signaling by FGFR1 in disease
- RAF/MAP kinase cascade
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- Signaling by FGFR3 fusions in cancer
- Signaling by FGFR3 point mutants in cancer
- RET signaling
- Activated NTRK2 signals through FRS2 and FRS3
- Activated NTRK2 signals through FRS2 and FRS3
|
|
|
|
FRS3 |
fibroblast growth factor receptor substrate 3 |
- FRS-mediated FGFR1 signaling
- FRS-mediated FGFR2 signaling
- FRS-mediated FGFR3 signaling
- FRS-mediated FGFR4 signaling
- RAF/MAP kinase cascade
- Activated NTRK2 signals through FRS2 and FRS3
|
|
|
|
GRB14 |
growth factor receptor bound protein 14 |
|
|
|
|
GRB2 |
growth factor receptor bound protein 2 |
- Interleukin-15 signaling
- Interleukin-15 signaling
- STAT5 activation downstream of FLT3 ITD mutants
- Signaling by FLT3 ITD and TKD mutants
- Signaling by FLT3 ITD and TKD mutants
|
- Pegademase
- 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
|
|
|
HTR1A |
5-hydroxytryptamine receptor 1A |
|
- Eletriptan
- Ziprasidone
- Methysergide
- Cabergoline
- Zolmitriptan
- Amitriptyline
- Olanzapine
- Clozapine
- Loxapine
- Pramipexole
- Methylphenidate
- Imipramine
- Chlorpromazine
- Buspirone
- Haloperidol
- Nortriptyline
- Amoxapine
- Propranolol
- Fenfluramine
- Lisuride
- Trazodone
- Sumatriptan
- Ergotamine
- Apomorphine
- Paroxetine
- Trimipramine
- Risperidone
- Alprenolol
- Ondansetron
- Naratriptan
- Pindolol
- Dopamine
- Ergoloid mesylate
- Doxepin
- Nefazodone
- Desipramine
- Escitalopram
- Pergolide
- Bromocriptine
- Ketamine
- Quetiapine
- Aripiprazole
- Chlorprothixene
- Paliperidone
- Penbutolol
- Yohimbine
- Acepromazine
- Alverine
- Molindone
- Pipotiazine
- Thioproperazine
- Lysergic acid diethylamide
- Dapoxetine
- Bifeprunox
- Flibanserin
- Iloperidone
- Lofexidine
- Lesopitron
- Rotigotine
- MN-305
- LI-301
- Naluzotan
- Cariprazine
- Mianserin
- Pizotifen
- Asenapine
- Xaliproden
- Dotarizine
- Sarizotan
- Repinotan
- Robalzotan
- Vilazodone
- Bopindolol
- Cinitapride
- Lurasidone
- Perospirone
- Cannabidiol
- Vortioxetine
- Brexpiprazole
- Dosulepin
- Pirlindole
- Tianeptine
- Setiptiline
- Dihydroergocornine
- Tetrahydrocannabivarin
- Pardoprunox
- Gilteritinib
- Tiapride
- Dihydroergocristine
- Medical Cannabis
- 5-methoxy-N,N-dimethyltryptamine
- Nabiximols
- Aripiprazole lauroxil
- SEP-363856
|
|
|
HULC |
hepatocellular carcinoma up-regulated long non-coding RNA |
|
|
|
|
IL17RD |
interleukin 17 receptor D |
- MAP2K and MAPK activation
|
|
|
|
ITK |
IL2 inducible T cell kinase |
- Generation of second messenger molecules
- FCERI mediated Ca+2 mobilization
- FCERI mediated Ca+2 mobilization
|
- Staurosporine
- Pazopanib
- Fostamatinib
- Zanubrutinib
|
|
|
KLB |
klotho beta |
- PI3K Cascade
- PIP3 activates AKT signaling
- betaKlotho-mediated ligand binding
- Constitutive Signaling by Aberrant PI3K in Cancer
- Phospholipase C-mediated cascade; FGFR4
- FRS-mediated FGFR4 signaling
- SHC-mediated cascade:FGFR4
- PI-3K cascade:FGFR4
- Negative regulation of FGFR4 signaling
- RAF/MAP kinase cascade
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
|
|
|
KPNB1 |
karyopherin subunit beta 1 |
- ISG15 antiviral mechanism
- Apoptosis induced DNA fragmentation
- Regulation of cholesterol biosynthesis by SREBP (SREBF)
- Transport of Ribonucleoproteins into the Host Nucleus
- NS1 Mediated Effects on Host Pathways
- Nuclear import of Rev protein
- Nuclear import of Rev protein
- Initiation of Nuclear Envelope (NE) Reformation
- Neutrophil degranulation
- Postmitotic nuclear pore complex (NPC) reformation
- Inhibition of nitric oxide production
|
|
|
|
LDHA |
lactate dehydrogenase A |
|
- NADH
- Etheno-NAD
- Nicotinamide
- Oxamic Acid
- Stiripentol
- Copper
- Artenimol
|
|
|
MFHAS1 |
malignant fibrous histiocytoma amplified sequence 1 |
|
|
|
|
NCAM1 |
neural cell adhesion molecule 1 |
- ECM proteoglycans
- NCAM signaling for neurite out-growth
- NCAM signaling for neurite out-growth
- NCAM1 interactions
- NCAM1 interactions
- Signal transduction by L1
- RAF/MAP kinase cascade
- Interferon gamma signaling
|
|
|
|
NCK1 |
NCK adaptor protein 1 |
- Downstream signal transduction
- Generation of second messenger molecules
- Regulation of actin dynamics for phagocytic cup formation
- Regulation of actin dynamics for phagocytic cup formation
- Nephrin family interactions
- DCC mediated attractive signaling
- DCC mediated attractive signaling
- Activation of RAC1
- VEGFA-VEGFR2 Pathway
- RHO GTPases Activate WASPs and WAVEs
- RHO GTPases Activate WASPs and WAVEs
- FCGR3A-mediated phagocytosis
- FCGR3A-mediated phagocytosis
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
|
|
|
NCK2 |
NCK adaptor protein 2 |
- Downstream signal transduction
- Nephrin family interactions
- Ephrin signaling
- Activation of RAC1
- VEGFA-VEGFR2 Pathway
- Regulation of cortical dendrite branching
|
|
|
|
NEDD4 |
NEDD4 E3 ubiquitin protein ligase |
- ISG15 antiviral mechanism
- Downregulation of ERBB4 signaling
- Regulation of PTEN localization
- Regulation of PTEN stability and activity
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
|
NRP1 |
neuropilin 1 |
- Neurophilin interactions with VEGF and VEGFR
- Signaling by ROBO receptors
- Sema3A PAK dependent Axon repulsion
- SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
- SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
- CRMPs in Sema3A signaling
- CRMPs in Sema3A signaling
- Signal transduction by L1
- CHL1 interactions
|
|
|
|
PDK1 |
pyruvate dehydrogenase kinase 1 |
- Regulation of pyruvate dehydrogenase (PDH) complex
- Signaling by Retinoic Acid
|
- 4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE
- Dichloroacetic acid
|
|
|
PIK3R1 |
phosphoinositide-3-kinase regulatory subunit 1 |
- PI3K Cascade
- IRS-mediated signalling
- GPVI-mediated activation cascade
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- PI3K events in ERBB4 signaling
- PIP3 activates AKT signaling
- Interleukin-7 signaling
- Interleukin-7 signaling
- Signaling by SCF-KIT
- Synthesis of PIPs at the plasma membrane
- GAB1 signalosome
- Signaling by cytosolic FGFR1 fusion mutants
- Downstream signal transduction
- PI3K events in ERBB2 signaling
- PI3K/AKT activation
- Downstream TCR signaling
- Role of phospholipids in phagocytosis
- Tie2 Signaling
- Constitutive Signaling by Aberrant PI3K in Cancer
- DAP12 signaling
- Role of LAT2/NTAL/LAB on calcium mobilization
- Nephrin family interactions
- Costimulation by the CD28 family
- CD28 dependent PI3K/Akt signaling
- G alpha (q) signalling events
- GP1b-IX-V activation signalling
- VEGFA-VEGFR2 Pathway
- VEGFA-VEGFR2 Pathway
- Interleukin-3, Interleukin-5 and GM-CSF signaling
- Constitutive Signaling by EGFRvIII
- PI-3K cascade:FGFR1
- PI-3K cascade:FGFR2
- PI-3K cascade:FGFR3
- PI-3K cascade:FGFR4
- Signaling by FGFR2 in disease
- Signaling by FGFR4 in disease
- Signaling by FGFR1 in disease
- RAF/MAP kinase cascade
- Interleukin-4 and Interleukin-13 signaling
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- MET activates PI3K/AKT signaling
- Signaling by FGFR3 fusions in cancer
- Signaling by FGFR3 point mutants in cancer
- RET signaling
- Extra-nuclear estrogen signaling
- Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
- Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
- Activated NTRK2 signals through PI3K
- Interleukin receptor SHC signaling
- Regulation of signaling by CBL
- Regulation of signaling by CBL
- Activated NTRK3 signals through PI3K
- FLT3 Signaling
- FLT3 Signaling
- Signaling by ERBB2 KD Mutants
- Signaling by ERBB2 ECD mutants
- Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
- Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
- Signaling by PDGFRA extracellular domain mutants
- Signaling by FLT3 fusion proteins
- Signaling by FLT3 fusion proteins
- Signaling by FLT3 ITD and TKD mutants
- Signaling by FLT3 ITD and TKD mutants
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
- Isoprenaline
- SF1126
- Enzastaurin
- Wortmannin
|
|